Evidence map›Paper›PMID 36033447›Full record

ArticleFrontiers in oncology2022

SpyGlass-Guided Photodynamic Therapy for Unresectable Cholangiocarcinoma: A Case Report and Review of the Literature.

Jiangjiao Zhou, Li Xiong, Wei Liu, Chun Liu, Chao He, Heng Zou, Yu Wen, Liangwu Lin

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jiangjiao ZhouDepartment of General Surgery, The Second Xiangya Hospital, Central South University, Changsha, China.
Li XiongDepartment of General Surgery, The Second Xiangya Hospital, Central South University, Changsha, China.
Wei LiuDepartment of General Surgery, The Second Xiangya Hospital, Central South University, Changsha, China.
Chun LiuDepartment of General Surgery, The Second Xiangya Hospital, Central South University, Changsha, China.
Chao HeDepartment of General Surgery, The Second Xiangya Hospital, Central South University, Changsha, China.
Heng ZouDepartment of General Surgery, The Second Xiangya Hospital, Central South University, Changsha, China.
Yu WenDepartment of General Surgery, The Second Xiangya Hospital, Central South University, Changsha, China.
Liangwu LinPowder Metallurgy Research Insititute, Central South University, Changsha, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Endoscopic retrograde cholangiopancreatography (ERCP) and biliary stent placement are standard palliative care procedures for patients with unresectable cholangiocarcinoma. However, the bile duct mucosa cannot be observed directly during the placement of a light diffuser in photodynamic therapy (PDT) and biopsy. SpyGlass can solve the above two problems. In this paper, we report the case of a patient who presented with obstructive jaundice and underwent endobiliary stenting placement several times. However, cholangiocarcinoma hyperplasia still led to stent blockage. We applied SpyGlass to guide the accurate placement of a light diffuser and evaluated the tumor necrosis after PDT. Results revealed the good application effect of this device.

Indexed as

Case reportcholangiocarcinomaERCPphotodynamic therapySpyGlass

Identifiers

PMID36033447
PMCPMC9399461

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.